![Logo for Acumen Pharmaceuticals Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F4500a-2023-03-22-10-08-51.png&w=256&q=100)
Acumen Pharmaceuticals Investor Relations Material
Latest events
![Logo for Acumen Pharmaceuticals Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F4500a-2023-03-22-10-08-51.png&w=128&q=100)
Q1 2024
Acumen Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Acumen Pharmaceuticals Inc
Access all reports
Acumen Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company primarily engaged in the discovery and development of therapies for the treatment of Alzheimer's disease. The company's most advanced candidate is ACU193, a humanized monoclonal antibody designed to target toxic soluble amyloid-beta oligomers. These amyloid-beta oligomers are associated with the neurodegeneration seen in Alzheimer’s disease patients. Acumen Pharmaceuticals was founded in 1996 and focuses on progressing its immunotherapy approach to offer potential disease-modifying treatments. The company is headquartered in Charlottesville, Virginia, and its shares are listed on the NASDAQ.
Key slides for Acumen Pharmaceuticals Inc
![PHARMACOKINETICS
S](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Facumen-pharmaceuticals-inc-corporate-presentation-818d2e7e322a7b24%2F19.png&w=3840&q=75)
![Logo for Acumen Pharmaceuticals Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F4500a-2023-03-22-10-08-51.png&w=128&q=100)
Corporate Presentation
Acumen Pharmaceuticals Inc
![TARGET ENGAGEMENT](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Facumen-pharmaceuticals-inc-jp-morgan-42nd-annual-healthcare-conference-2024-b6aa852ff6c03ff6%2F9.png&w=3840&q=75)
![Logo for Acumen Pharmaceuticals Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F4500a-2023-03-22-10-08-51.png&w=128&q=100)
J.P. Morgan 42nd Annual Healthcare Conference 2024
Acumen Pharmaceuticals Inc
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F1882x1059%2F7e17876154%2Fbirkin.png&w=3840&q=75)
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2688x1512%2F8365aa8316%2Ftop-10-largest-semiconductor-companies.png&w=3840&q=75)
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F135c0e3f6b%2Fthe-rise-of-nubank.png&w=3840&q=75)
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
ABOS
Country
🇺🇸 United States